Alterations of bone metabolism in patients with chronic C virus hepatitis;Alterazioni del metabolismo osseo in pazienti con epatite cronica da virus C

Infezioni in Medicina

Volumn 13, Issue 1, 2005, Pages 23-27

  Luchi, Sauro ^a   Fiorini, Italbo ^b   Meini, Micaela ^a   Scasso, Antonio ^a  

^a Liver Disease Centre   (Italy)

^b Clinical Biochemistry Department   (Italy)

Author keywords

Chronic hepatitis C; Hepatic osteodystrophy; Osteoporosis

Indexed keywords

BIOCHEMICAL MARKER;

ADULT; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE REMODELING; CONTROLLED STUDY; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEASUREMENT; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PARAMETER; RISK FACTOR;

ADULT; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; CHI-SQUARE DISTRIBUTION; DENSITOMETRY; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; OSTEOCLASTS; OSTEOPOROSIS; RISK FACTORS;

EID: 18444387127     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rouillard S., Lane N. E. Hepatic osteodystrophy. Hepatology 33, 301-307, 2001.
2. Heathcote E.J. Management of primary biliary cirrhosis. Hepatology 31, 1005-1013, 2000.
3. Idilman R., De Maria N., Uzunalimoglu O., Van Thiel D.H. Hepatic osteodystrophy: A review. Hepato-Gastroenterology 44, 574-581, 1997.
4. Collier J.D, Ninkovic M., Compston J.E. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50, i1-i9, 2002.
5. Diamond T., Stiel D., Lunzer M., Wilkinson M., Roche J., Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 31, 82-83, 1990
6. Chen C.C., Wang S.S., Jeng F.S., Lee S.D. Metabolic bone disease of liver cirrhosis: Is it parallel to the clinical severity of cirrhosis? J. Gastroenterol. Hepatol. 11, 417-421, 1996.
7. Solis-Herruzo J.A., Castellano G., Fernànez I., Munoz R., Hawkins F. Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatits C. J. Hepatol. 33, 812-817, 2000.
8. McCaughan G.W., Feller R.B. Oteoporosis in chronic liver disease: pathogenesis, risk factors and management. Dig. Dis. 12, 23-231, 1994.
9. Schiefke I., Borte G., Wiese M., Schenker E. Decreased bone mineral density in non cirrhotic patients with chronic hepatitis B or C. J. Hepatol. 36, 106, 2002
10. Eriksen E.F., Kassem M., Langdahl B. Growth hormone, insulin like growth factors and bone remodelling. Eur. J. Clin. Invest. 26, 525-534, 1996.
11. Slootweg M.C., Hoogerbrugge C.M., de Poorter T.L., Duursma S.A., Van Buul Offers S.C. The presence of classical insuline-like growth factor (IGF) type-I and II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGF's? J. Endocrinol. 125, 271-277, 1990.
12. Hodgson S.F., Dickon E.R. Bone loss and reduced osteoblast function in PBC. Ann. Int. Med. 103, 855-860, 1985.
13. Bell H., Raknerud N., Falch J.A., Haug E. Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis. Eur. J. Endocrinol. 132, 444-449, 1995.
14. Compston J.E., Thompson R.P.H. Intestinal absorption of 25 hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet, 2, 1 (8014), 721-724, 1977.
15. Simonet W.S., Lacey D.L., Dunstan C.R. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 89, 309-319, 1997.
16. Adler R.A., Rosen C.J. Glucocorticoids and osteoporosis. Endocrinol. Metab. Clin.; 23, 641-654, 1994.
17. Chappard D., Plantard B., Fraisse H., Palle S., Alexandre C., Riffat G. Bone changes in alcoholic cirrhosis of the liver. A histomorphometric study. Pathol. Res. Pract. 18, 480-485, 1989.
18. Edelson G.W., Kleerkoper M. Utilizzo dei marcatori biochimici dell'osso nell'osteoporosi. J. Clin. Lig. Assay 21, 128-137, 1998.
19. Pedersen B.J., Ravn P., Bonde M. Prodotti di degradazione del C-telopeptide del collageno di tipo I come marcatori del riassorbimento osseo. J. Clin. Lig. Assay 21, 128-137,1998.
20. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696-702, 1995.
21. Crosbie O.M., Freaney R., McKenna M.J., Hegarty J.E. Bone density, vitamin D status, and disordered bone remodelling in end-stage chronic liver disease. Calcif. Tissue Int. 64, 295-300, 1999.
22. Luchi S., Fiorini I., Tarchi R., Vincenti A., Scasso A. Osteodistrofia epatica. Pandora 3, 9-13, 2001.
23. Fiorini I., Scasso A., Luchi S. et al. A comparison between serum and urinary crosslaps in healthy and osteopenic males. Giornale Italiano di Andrologia 1, 23-25, 2003.